These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 32909410)

  • 21. Beyond gut feelings: how the gut microbiota regulates blood pressure.
    Marques FZ; Mackay CR; Kaye DM
    Nat Rev Cardiol; 2018 Jan; 15(1):20-32. PubMed ID: 28836619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiota dysbiosis contributes to the development of hypertension.
    Li J; Zhao F; Wang Y; Chen J; Tao J; Tian G; Wu S; Liu W; Cui Q; Geng B; Zhang W; Weldon R; Auguste K; Yang L; Liu X; Chen L; Yang X; Zhu B; Cai J
    Microbiome; 2017 Feb; 5(1):14. PubMed ID: 28143587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice.
    Marques FZ; Nelson E; Chu PY; Horlock D; Fiedler A; Ziemann M; Tan JK; Kuruppu S; Rajapakse NW; El-Osta A; Mackay CR; Kaye DM
    Circulation; 2017 Mar; 135(10):964-977. PubMed ID: 27927713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation.
    Rahman MM; Islam F; -Or-Rashid MH; Mamun AA; Rahaman MS; Islam MM; Meem AFK; Sutradhar PR; Mitra S; Mimi AA; Emran TB; Fatimawali ; Idroes R; Tallei TE; Ahmed M; Cavalu S
    Front Cell Infect Microbiol; 2022; 12():903570. PubMed ID: 35795187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart Failure.
    Sata Y; Marques FZ; Kaye DM
    Curr Hypertens Rep; 2020 May; 22(5):38. PubMed ID: 32385705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension as a Metabolic Disorder and the Novel Role of the Gut.
    Tanaka M; Itoh H
    Curr Hypertens Rep; 2019 Jun; 21(8):63. PubMed ID: 31236708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease.
    Feng YL; Cao G; Chen DQ; Vaziri ND; Chen L; Zhang J; Wang M; Guo Y; Zhao YY
    Cell Mol Life Sci; 2019 Dec; 76(24):4961-4978. PubMed ID: 31147751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut microbiota, hypertension and chronic kidney disease: Recent advances.
    Sircana A; De Michieli F; Parente R; Framarin L; Leone N; Berrutti M; Paschetta E; Bongiovanni D; Musso G
    Pharmacol Res; 2019 Jun; 144():390-408. PubMed ID: 29378252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal androgen exposure causes hypertension and gut microbiota dysbiosis.
    Sherman SB; Sarsour N; Salehi M; Schroering A; Mell B; Joe B; Hill JW
    Gut Microbes; 2018; 9(5):400-421. PubMed ID: 29469650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gut Microbiota in Cardiovascular Health and Disease.
    Tang WH; Kitai T; Hazen SL
    Circ Res; 2017 Mar; 120(7):1183-1196. PubMed ID: 28360349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression.
    Mosterd CM; Kanbay M; van den Born BJH; van Raalte DH; Rampanelli E
    Best Pract Res Clin Endocrinol Metab; 2021 May; 35(3):101484. PubMed ID: 33546983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of short-chain fatty acid on blood pressure regulation.
    Miyamoto J; Kasubuchi M; Nakajima A; Irie J; Itoh H; Kimura I
    Curr Opin Nephrol Hypertens; 2016 Sep; 25(5):379-83. PubMed ID: 27490782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
    Arab JP; Martin-Mateos RM; Shah VH
    Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease.
    Meijers B; Jouret F; Evenepoel P
    Pharmacol Res; 2018 Jul; 133():101-107. PubMed ID: 29715498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiota and cardiovascular diseases axis.
    Moldovan DC; Ismaiel A; Fagoonee S; Pellicano R; Abenavoli L; Dumitrascu DL
    Minerva Med; 2022 Feb; 113(1):189-199. PubMed ID: 33969961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gut microbiota-derived short-chain fatty acids and kidney diseases.
    Li L; Ma L; Fu P
    Drug Des Devel Ther; 2017; 11():3531-3542. PubMed ID: 29270002
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
    Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
    Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Microbiota and Metabolic Disorders: Advances in Therapeutic Interventions.
    Akash MSH; Fiayyaz F; Rehman K; Sabir S; Rasool MH
    Crit Rev Immunol; 2019; 39(4):223-237. PubMed ID: 32421966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.